22 May 2013
Keywords: alkermes, starts, ph, iii, trial, naltrexone, xr
Article | 15 April 2002
Alkermes of the USA has started a pivotal, 400-patient clinical trial ofVivitrex, an extended-release formulation of the opiate antagonist
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 April 2002
© 2013 thepharmaletter.com